On August 29, the website of the administrative service department under the original China FDA released a document on the new offering procedure of drug registration application.

In the document, it says that the English name of China FDA has been changed to “National Medical Products Administration “NMPA”, so applicants who submit the materials beginning in September should use the new application letter with the new name on it.

The original name China FDA has been used since 2008. (Source: cnzqxx.com)

Comments are closed.